Dr. Sankin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Bronx, NY 10467Phone+1 718-920-4321Fax+1 718-920-8543
Education & Training
New York University School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2013 - 2026- American Board of Urology Urology
Publications & Presentations
PubMed
- 78 citationsImpact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Mehmet Asim Bilen, Victor Sacristan Santos
Cancer. 2020-03-15 - 34 citationsSystematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancerKara L. Watts, Laena Frechette, Ben Muller, Dan Ilinksy, Evan Kovac
Urologic Oncology. 2020-04-19 - 60 citationsA review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.Tian C. Zhou, Alexander Sankin, Steven A. Porcelli, David S. Perlin, Mark Schoenberg
Urologic Oncology. 2017-01-01
Press Mentions
- Prostate Cancer Treatment Considerations in Patients of Low Socioeconomic StatusNovember 1st, 2020
New Checkpoint Target Emerges in Bladder CancerAugust 4th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
